KRMD (KORU Medical Systems) Beneish M-Score: -2.92 (As of Jul. 08, 2026)


KRMD KORU Medical Systems Inc KRMD
76 GF Score
Price $4.44
GF Value $4.08
Valuation Fairly Valued
View Full Analysis

What is KORU Medical Systems Beneish M-Score?

KORU Medical Systems KRMD -3.27% 76 Beneish M-Score is -2.92 as of Jul. 08, 2026. GuruFocus rates KRMD with a GF Score™ of 76/100 and a GF Value™ of $4.08 (Fairly Valued). Among 763 Medical Devices & Instruments companies, KORU Medical Systems ranks better than 74.57% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.92 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for KORU Medical Systems's Beneish M-Score or its related term are showing as below:

KRMD' s Beneish M-Score Range Over the Past 10 Years
Min: -5.24   Med: -2.43   Max: -0.32
Current: -2.92

During the past 13 years, the highest Beneish M-Score of KORU Medical Systems was -0.32. The lowest was -5.24. And the median was -2.43.


KORU Medical Systems Beneish M-Score Historical Data

* Premium members only.

The historical data trend for KORU Medical Systems's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KORU Medical Systems Beneish M-Score Chart

KORU Medical Systems Annual Data
Trend Feb16 Feb17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.41 -2.52 -4.41 -3.20 -2.91

KORU Medical Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.18 -3.28 -3.15 -2.91 -2.92

KRMD vs EMBC, PDEX, SMTI: Beneish M-Score Comparison

For the Medical Instruments & Supplies subindustry, KORU Medical Systems's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KORU Medical Systems Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, KORU Medical Systems's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where KORU Medical Systems's Beneish M-Score falls into.


KRMD
76GF Score
KORU Medical Systems Inc KRMD
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

KORU Medical Systems Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of KORU Medical Systems for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8171+0.528 * 1.0252+0.404 * 0.9472+0.892 * 1.233+0.115 * 1.0672
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8756+4.679 * -0.105904-0.327 * 1.0218
=-2.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was $6.32 Mil.
Revenue was 11.765 + 10.895 + 10.402 + 10.195 = $43.26 Mil.
Gross Profit was 7.231 + 6.817 + 6.265 + 6.476 = $26.79 Mil.
Total Current Assets was $20.59 Mil.
Total Assets was $28.59 Mil.
Property, Plant and Equipment(Net PPE) was $7.19 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.79 Mil.
Selling, General, & Admin. Expense(SGA) was $24.00 Mil.
Total Current Liabilities was $8.85 Mil.
Long-Term Debt & Capital Lease Obligation was $2.82 Mil.
Net Income was -0.807 + -0.487 + -0.778 + -0.207 = $-2.28 Mil.
Non Operating Income was -0.023 + -0.002 + 0.015 + 0.044 = $0.03 Mil.
Cash Flow from Operations was 0.015 + 1.095 + 0.065 + -0.46 = $0.72 Mil.
Total Receivables was $6.27 Mil.
Revenue was 9.635 + 8.839 + 8.18 + 8.43 = $35.08 Mil.
Gross Profit was 6.046 + 5.563 + 5.186 + 5.48 = $22.28 Mil.
Total Current Assets was $19.00 Mil.
Total Assets was $27.22 Mil.
Property, Plant and Equipment(Net PPE) was $7.40 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.87 Mil.
Selling, General, & Admin. Expense(SGA) was $22.23 Mil.
Total Current Liabilities was $7.80 Mil.
Long-Term Debt & Capital Lease Obligation was $3.07 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(6.318 / 43.257) / (6.271 / 35.084)
=0.146057 / 0.178742
=0.8171

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(22.275 / 35.084) / (26.789 / 43.257)
=0.634905 / 0.619299
=1.0252

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (20.588 + 7.193) / 28.592) / (1 - (18.999 + 7.402) / 27.216)
=0.028365 / 0.029946
=0.9472

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=43.257 / 35.084
=1.233

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.874 / (0.874 + 7.402)) / (0.79 / (0.79 + 7.193))
=0.105607 / 0.09896
=1.0672

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(24.002 / 43.257) / (22.234 / 35.084)
=0.55487 / 0.633736
=0.8756

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2.818 + 8.852) / 28.592) / ((3.072 + 7.799) / 27.216)
=0.408156 / 0.399434
=1.0218

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-2.279 - 0.034 - 0.715) / 28.592
=-0.105904

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

KORU Medical Systems has a M-score of -2.92 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.92 mean?
KORU Medical Systems (KRMD) has a Beneish M-Score of -2.92 as of Jul. 08, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on KORU Medical Systems and its competitors. According to the industry distribution chart, KORU Medical Systems ranks #194 out of 763 companies in the Medical Devices & Instruments industry, placing it in the top 25.4%.
Is KORU Medical Systems' Beneish M-Score too high?
KORU Medical Systems' current Beneish M-Score is -2.92. Based on the distribution chart, KORU Medical Systems ranks #194 out of 763 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, KORU Medical Systems has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KORU Medical Systems' Beneish M-Score compare to EMBC and PDEX?
According to the Medical Devices & Instruments industry distribution chart, KORU Medical Systems ranks #194 out of 763 companies for Beneish M-Score. This puts KORU Medical Systems in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on KORU Medical Systems and its competitors. KORU Medical Systems's current Beneish M-Score is -2.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KORU Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, KORU Medical Systems (KRMD) is currently considered Fairly Valued. The stock's GF Value™ is $4.08, compared to a current price of $4.44 — trading 8.8% above its estimated fair value. The current Beneish M-Score is -2.92. KORU Medical Systems' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For KORU Medical Systems (KRMD), the current Beneish M-Score is -2.92 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is KORU Medical Systems (KRMD) Overvalued in 2026?

Based on GuruFocus' analysis, KORU Medical Systems stock appears to be overvalued. The current stock price of $4.44 is trading 8.8% above its estimated GF Value™ of $4.08. GuruFocus considers KORU Medical Systems to be Fairly Valued.

Key valuation signals for KRMD:

  • Beneish M-Score: -2.92
  • GF Value™: $4.08 vs. price of $4.44 (8.8% above fair value)
  • GF Score™: 76/100

No single metric tells the full story. See the KRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


KORU Medical Systems Business Description

Address 100 Corporate Drive, Mahwah, NJ, USA, 07430
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
76GF Score

Get the complete analysis for KRMD

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.44
Price
$4.08
GF Value